Smart-Money SignalDistribution · 37/100— Insiders are net sellers over 90 days (-$11.7M, 12 sales vs 6 buys)
Revenue$31.7M
Net Income-$94.3M
EPS$-0.91
Market Cap$3.8B
Price Performance
Historical data including institutional events
Company Profile
J
John Evans
CEO & Executive Director
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.
